AIMS: To evaluate whether C-reactive protein (CRP) levels on admission are predictive of myocardial salvage achieved with different reperfusion strategies in patients with acute myocardial infarction (AMI). METHODS AND RESULTS:Patients with AMI treated withstenting plus abciximab (n=125) and thrombolysis alone (n=54) or withabciximab (n=71) were prospectively studied. CRP levels were measured by a high sensitivity assay. The threshold of the upper quartile (12 mg/l) was used to divide patients into two groups: 60 patients with high CRP (>12 mg/l) and 190 patients with low CRP (< or =12 mg/l). Myocardial salvage was measured by technetium (Tc)-99(m)sestamibi scintigraphy. Patients in the high CRP group had a significantly lower salvage index (0.35+/-0.42 vs 0.48+/-0.34, p=0.01) and higher 18-month mortality (11.7 vs 3.2%, p=0.03) compared to those in the low CRP group. While basal CRP was not related to myocardial salvage in patients treated with stenting plus abciximab (p=0.89) or thrombolysis plus abciximab (p=0.43), a high CRP on admission was associated with a significantly lower salvage index (0.09+/-0.48 vs 0.42+/-0.37 in the low CRP group, p=0.006) among patients treated with thrombolysis alone. CONCLUSION:CRP levels on admission may predict the efficacy of reperfusion in patients with AMI. The predictive ability is dependent on the form of reperfusion therapy.
RCT Entities:
AIMS: To evaluate whether C-reactive protein (CRP) levels on admission are predictive of myocardial salvage achieved with different reperfusion strategies in patients with acute myocardial infarction (AMI). METHODS AND RESULTS:Patients with AMI treated with stenting plus abciximab (n=125) and thrombolysis alone (n=54) or with abciximab (n=71) were prospectively studied. CRP levels were measured by a high sensitivity assay. The threshold of the upper quartile (12 mg/l) was used to divide patients into two groups: 60 patients with high CRP (>12 mg/l) and 190 patients with low CRP (< or =12 mg/l). Myocardial salvage was measured by technetium (Tc)-99(m)sestamibi scintigraphy. Patients in the high CRP group had a significantly lower salvage index (0.35+/-0.42 vs 0.48+/-0.34, p=0.01) and higher 18-month mortality (11.7 vs 3.2%, p=0.03) compared to those in the low CRP group. While basal CRP was not related to myocardial salvage in patients treated with stenting plus abciximab (p=0.89) or thrombolysis plus abciximab (p=0.43), a high CRP on admission was associated with a significantly lower salvage index (0.09+/-0.48 vs 0.42+/-0.37 in the low CRP group, p=0.006) among patients treated with thrombolysis alone. CONCLUSION:CRP levels on admission may predict the efficacy of reperfusion in patients with AMI. The predictive ability is dependent on the form of reperfusion therapy.
Authors: S G Foussas; M N Zairis; S S Makrygiannis; S J Manousakis; F A Anastassiadis; C S Apostolatos; N G Patsourakos; M P Glyptis; J K Papadopoulos; D C Xenos; E N Adamopoulou; C D Olympios; S K Argyrakis Journal: Heart Date: 2007-03-07 Impact factor: 5.994
Authors: Mariusz Kruk; Jakub Przyłuski; Lukasz Kalińczuk; Jerzy Pręgowski; Edyta Kaczmarska; Joanna Petryka; Cezary Kępka; Paweł Bekta; Zbigniew Chmielak; Marcin Demkow; Andrzej Ciszewski; Maciej Karcz; Mariusz Kłopotowski; Adam Witkowski; Witold Rużyłło Journal: Postepy Kardiol Interwencyjnej Date: 2013-09-16 Impact factor: 1.426
Authors: Christian Stumpf; Ahmed Sheriff; Stefan Zimmermann; Liane Schaefauer; Christian Schlundt; Dorette Raaz; Christoph D Garlichs; Stephan Achenbach Journal: Arch Med Sci Date: 2017-08-03 Impact factor: 3.318